BR0115727A - Formulações dermatológicas - Google Patents

Formulações dermatológicas

Info

Publication number
BR0115727A
BR0115727A BR0115727-2A BR0115727A BR0115727A BR 0115727 A BR0115727 A BR 0115727A BR 0115727 A BR0115727 A BR 0115727A BR 0115727 A BR0115727 A BR 0115727A
Authority
BR
Brazil
Prior art keywords
dermatological formulations
acne
clindamycin
erythematosus
zinc salt
Prior art date
Application number
BR0115727-2A
Other languages
English (en)
Inventor
Emma Louise Mcdonagh
Rebecca Louise Kanis
Original Assignee
Kanford B V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kanford B V filed Critical Kanford B V
Publication of BR0115727A publication Critical patent/BR0115727A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

"FORMULAçõES DERMATOLóGICAS". A presente invenção refere-se a preparações aquosas de quantidades substancialmente equimolares de um sal de zinco e fosfato de clindamicina formam um polímero utilizável no tratamento tópico de acne e acne eritematosa, com níveis sistêmicos muito baixos de clindamicina.
BR0115727-2A 2000-11-28 2001-11-28 Formulações dermatológicas BR0115727A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0029018.9A GB0029018D0 (en) 2000-11-28 2000-11-28 Dermatological formulations
PCT/GB2001/005257 WO2002043739A2 (en) 2000-11-28 2001-11-28 Dermatological formulations containing clindamycin and a zinc-salt

Publications (1)

Publication Number Publication Date
BR0115727A true BR0115727A (pt) 2003-10-14

Family

ID=9904040

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0115727-2A BR0115727A (pt) 2000-11-28 2001-11-28 Formulações dermatológicas

Country Status (24)

Country Link
US (2) US20040109902A1 (pt)
EP (1) EP1347765B1 (pt)
JP (1) JP4272425B2 (pt)
KR (1) KR100629326B1 (pt)
AT (1) ATE321560T1 (pt)
AU (2) AU2309102A (pt)
BR (1) BR0115727A (pt)
CA (1) CA2429205C (pt)
CZ (1) CZ305272B6 (pt)
DE (1) DE60118441T2 (pt)
DK (1) DK1347765T3 (pt)
ES (1) ES2263689T3 (pt)
GB (1) GB0029018D0 (pt)
HR (1) HRP20030433B1 (pt)
HU (1) HUP0400520A3 (pt)
IL (1) IL152720A0 (pt)
MX (1) MXPA03004733A (pt)
NZ (1) NZ526170A (pt)
PL (1) PL207221B1 (pt)
PT (1) PT1347765E (pt)
RU (1) RU2277419C2 (pt)
SK (1) SK288111B6 (pt)
WO (1) WO2002043739A2 (pt)
ZA (1) ZA200305012B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101324578B1 (ko) 2006-02-03 2013-11-01 제이알 켐, 엘엘씨 구리 및 아연 조성물을 사용하는 노화 방지 치료법
US7897800B2 (en) 2006-02-03 2011-03-01 Jr Chem, Llc Chemical compositions and methods of making them
US7687650B2 (en) 2006-02-03 2010-03-30 Jr Chem, Llc Chemical compositions and methods of making them
US7867522B2 (en) 2006-09-28 2011-01-11 Jr Chem, Llc Method of wound/burn healing using copper-zinc compositions
JP5244917B2 (ja) * 2007-11-30 2013-07-24 ノバルティス アーゲー Ｃ２−ｃ５−アルキル−イミダゾール−ビスホスホネート類
US8273791B2 (en) 2008-01-04 2012-09-25 Jr Chem, Llc Compositions, kits and regimens for the treatment of skin, especially décolletage
CA2750636C (en) 2009-01-23 2017-07-25 Jr Chem, Llc Rosacea treatments and kits for performing them
AU2010238566B2 (en) * 2010-11-01 2012-09-20 Stiefel Research Australia Pty Ltd Polymeric topical compositions
US8481591B2 (en) 2010-11-01 2013-07-09 Stiefel Research Australia Pty. Ltd. Polymeric topical compositions
US8952057B2 (en) 2011-01-11 2015-02-10 Jr Chem, Llc Compositions for anorectal use and methods for treating anorectal disorders
US9023399B2 (en) 2012-11-16 2015-05-05 NU Technology, LLC Water-soluble anti-inflammatory cream with natural ingredients base
US8613961B1 (en) 2013-01-09 2013-12-24 NU Technology, LLC Dermatological cream with natural ingredients base
CN109498564B (zh) * 2018-12-21 2021-04-16 贵州景峰注射剂有限公司 一种克林霉素磷酸酯配液及其制备方法
US20230000892A1 (en) * 2021-06-30 2023-01-05 Kenneth Okafor Solution, Lotion, Gel, and Cream for Use to Prevent Razor Bumps

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4621075A (en) * 1984-11-28 1986-11-04 The Procter & Gamble Company Gel-form topical antibiotic compositions
US4895727A (en) * 1985-05-03 1990-01-23 Chemex Pharmaceuticals, Inc. Pharmaceutical vehicles for exhancing penetration and retention in the skin
JPS6251619A (ja) * 1985-08-30 1987-03-06 Wako Pure Chem Ind Ltd 外用ゲル製剤
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
JP3981151B2 (ja) * 1994-03-28 2007-09-26 ザ トラスティーズ オブ コロンビア ユニバーシティー イン ザ シティー オブ ニューヨーク 液体中の刺激物を不活化するための組成物
FR2728166A1 (fr) * 1994-12-19 1996-06-21 Oreal Composition topique contenant un antagoniste de substance p
US5648389A (en) * 1995-10-27 1997-07-15 Medicis Pharmaceutical, Inc. Compositions for the treatment of dermatological disorders and methods for their use

Also Published As

Publication number Publication date
MXPA03004733A (es) 2005-02-14
SK288111B6 (sk) 2013-08-02
NZ526170A (en) 2006-01-27
JP2004517829A (ja) 2004-06-17
HRP20030433B1 (hr) 2007-10-31
US20040109902A1 (en) 2004-06-10
EP1347765A2 (en) 2003-10-01
US8268790B2 (en) 2012-09-18
CZ305272B6 (cs) 2015-07-15
WO2002043739A2 (en) 2002-06-06
IL152720A0 (en) 2003-06-24
HRP20030433A2 (en) 2004-08-31
AU2002223091B2 (en) 2006-08-31
HUP0400520A2 (hu) 2004-07-28
SK6322003A3 (en) 2003-12-02
JP4272425B2 (ja) 2009-06-03
RU2277419C2 (ru) 2006-06-10
PT1347765E (pt) 2006-08-31
EP1347765B1 (en) 2006-03-29
DE60118441D1 (de) 2006-05-18
US20100173855A1 (en) 2010-07-08
AU2309102A (en) 2002-06-11
DK1347765T3 (da) 2006-08-07
CZ20031491A3 (cs) 2004-01-14
WO2002043739A3 (en) 2003-05-01
ATE321560T1 (de) 2006-04-15
GB0029018D0 (en) 2001-01-10
KR20030069793A (ko) 2003-08-27
CA2429205A1 (en) 2002-06-06
KR100629326B1 (ko) 2006-09-29
PL362279A1 (en) 2004-10-18
HUP0400520A3 (en) 2012-08-28
CA2429205C (en) 2010-11-16
ES2263689T3 (es) 2006-12-16
DE60118441T2 (de) 2006-11-16
PL207221B1 (pl) 2010-11-30
ZA200305012B (en) 2005-04-26
HK1059218A1 (en) 2004-06-25

Similar Documents

Publication Publication Date Title
BR0115727A (pt) Formulações dermatológicas
BRPI0317696B8 (pt) composição para branqueamento
BR9709079A (pt) Composição cosmética para rejuvenescimento da pele sem irritação da mesma
BR0114059A (pt) Derivados de resorcinol
FR2807322B1 (fr) Composition, notamment cosmetique, comprenant de l'acide ascorbique en association avec un derive d'acide ascorbique
DE69900081D1 (de) Haut- und/oder Haardepigmentierungsmittel
ES2181812T3 (es) Formulaciones y procedimientos para reducir la irritacion de la piel.
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
ES2177323T3 (es) Preparaciones de insulina concentradas estables para la administracionpor via pulmonar.
HN1999000132A (es) Trifluorometilpirrolcarboxamidas
BR9803596A (pt) Derivados do resorcinol.
BR0113798A (pt) Derivados de resorcinol
ATE370730T1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
BR9916423A (pt) Formulação de baixo ponto de congelamento contendo fenol e/ou derivados de fenol
BR0304298A (pt) Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume
ATE256392T1 (de) Verwendung von polyaminosäurederivate als konservierungsmittel
BR9903750B1 (pt) utilização não terapêutica de pelo menos um extrato de rosácea do gênero sanguisorba e processo cosmético de pigmentação da pele.
IS6654A (is) Stöðugt gabapentín með pH innan stýrðra marka
BR0100827A (pt) Fator estimulador de colÈnias de granulócitosestabilizado
WO2001062208A3 (de) Topische kosmetische mittel enthaltend 2-hydrazino-1,3-heteroazole
AU2094200A (en) Cosmetic or medical preparation for topical use
WO1999011256A8 (en) L-threonate ferrous, as well as pharmaceutical composition and use for improving and treating human anemia thereof
BR0009194A (pt) Composição do resorcinol
BR0214259A (pt) Composição aquosa de tratamento capilar, uso da mesma e método para tratamento dos cabelos
BR0010699A (pt) Benzimidazóis substituìdos, sua produção e utilização dos mesmos como agente contra protozoários parasitários

Legal Events

Date Code Title Description
B25G Requested change of headquarter approved

Owner name: KANFORD B.V. (NL)

Free format text: SEDE ALTERADA CONFORME SOLICITADO NA PETICAO NO 020090100696/RJ DE 27/10/2009.

B25A Requested transfer of rights approved

Owner name: STRAKAN INTERNATIONAL LIMITED (GB)

Free format text: TRANSFERIDO DE: KANFORD B.V.

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2258 DE 15/04/2014.